tiprankstipranks
Trending News
More News >
Ironwood Pharmaceuticals (IRWD)
:IRWD
US Market
Advertisement

Ironwood Pharma (IRWD) Ratios

Compare
317 Followers

Ironwood Pharma Ratios

IRWD's free cash flow for Q1 2025 was $1.00. For the 2025 fiscal year, IRWD's free cash flow was decreased by $ and operating cash flow was $-0.69. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.34 0.84 30.58 4.61 15.16
Quick Ratio
3.34 0.84 30.53 4.60 15.16
Cash Ratio
2.26 0.33 25.71 3.84 11.08
Solvency Ratio
-0.04 -1.22 0.39 1.02 0.22
Operating Cash Flow Ratio
1.63 0.66 10.73 1.62 5.16
Short-Term Operating Cash Flow Coverage
24.51 0.92 89.32 2.24 53.98
Net Current Asset Value
$ -500.69M$ -584.08M$ 332.49M$ 224.21M$ -759.00K
Leverage Ratios
Debt-to-Assets Ratio
1.83 1.52 0.38 0.42 0.81
Debt-to-Equity Ratio
-1.79 -2.07 0.64 0.79 7.24
Debt-to-Capital Ratio
2.26 1.94 0.39 0.44 0.88
Long-Term Debt-to-Capital Ratio
2.34 3.28 0.38 0.36 0.87
Financial Leverage Ratio
-0.98 -1.36 1.69 1.86 8.93
Debt Service Coverage Ratio
0.08 -4.56 17.26 3.79 4.27
Interest Coverage Ratio
1.63 -43.71 32.95 7.46 4.85
Debt to Market Cap
5.16 0.39 0.21 0.24 0.24
Interest Debt Per Share
3.93 4.74 2.74 3.12 3.03
Net Debt to EBITDA
8.24 -0.67 -0.92 -0.62 0.64
Profitability Margins
Gross Profit Margin
99.69%76.33%99.65%99.63%99.19%
EBIT Margin
18.15%44.23%63.33%56.03%35.51%
EBITDA Margin
18.74%-208.90%63.67%56.39%36.43%
Operating Profit Margin
17.25%-213.54%60.97%56.13%36.70%
Pretax Profit Margin
7.54%-214.14%61.48%48.50%27.95%
Net Profit Margin
-9.89%-226.37%42.64%127.72%27.26%
Continuous Operations Profit Margin
-10.18%-233.00%42.64%127.72%27.26%
Net Income Per EBT
-131.05%105.71%69.35%263.36%97.53%
EBT Per EBIT
43.74%100.28%100.83%86.39%76.16%
Return on Assets (ROA)
-9.60%-212.76%15.91%46.89%18.99%
Return on Equity (ROE)
9.91%289.42%26.83%87.22%169.50%
Return on Capital Employed (ROCE)
19.63%-484.91%23.29%24.06%27.15%
Return on Invested Capital (ROIC)
-26.02%-258.69%16.06%56.36%26.17%
Return on Tangible Assets
-9.68%-214.43%15.69%45.90%19.01%
Earnings Yield
-28.40%-56.36%9.15%27.93%5.85%
Efficiency Ratios
Receivables Turnover
7.99 3.43 3.56 3.63 3.18
Payables Turnover
0.17 13.38 2.94 1.63 4.74
Inventory Turnover
0.00 0.00 1.13 1.22 3.14M
Fixed Asset Turnover
21.36 24.36 20.22 18.05 15.27
Asset Turnover
0.97 0.94 0.37 0.37 0.70
Working Capital Turnover Ratio
2.48 1.24 0.61 0.79 1.07
Cash Conversion Cycle
-2.10K 79.18 300.07 176.10 37.71
Days of Sales Outstanding
45.69 106.45 102.64 100.60 114.65
Days of Inventory Outstanding
0.00 0.00 321.76 299.57 <0.01
Days of Payables Outstanding
2.15K 27.27 124.33 224.08 76.93
Operating Cycle
45.69 106.45 424.39 400.18 114.65
Cash Flow Ratios
Operating Cash Flow Per Share
0.49 1.18 1.77 1.61 1.06
Free Cash Flow Per Share
0.49 1.18 1.77 1.61 1.05
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 0.99
Dividend Paid and CapEx Coverage Ratio
747.79 671.89 2.01K 988.28 91.66
Capital Expenditure Coverage Ratio
747.79 671.89 2.01K 988.28 91.66
Operating Cash Flow Coverage Ratio
0.13 0.26 0.66 0.55 0.37
Operating Cash Flow to Sales Ratio
0.25 0.41 0.67 0.63 0.43
Free Cash Flow Yield
70.53%10.30%14.31%13.83%9.20%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-3.61 -1.77 10.93 3.58 17.10
Price-to-Sales (P/S) Ratio
0.36 4.02 4.66 4.57 4.66
Price-to-Book (P/B) Ratio
-0.34 -5.13 2.93 3.12 28.99
Price-to-Free Cash Flow (P/FCF) Ratio
1.45 9.71 6.99 7.23 10.87
Price-to-Operating Cash Flow Ratio
1.44 9.69 6.99 7.22 10.76
Price-to-Earnings Growth (PEG) Ratio
<0.01 <0.01 -0.17 <0.01 -0.02
Price-to-Fair Value
-0.34 -5.13 2.93 3.12 28.99
Enterprise Value Multiple
10.16 -2.60 6.40 7.49 13.44
Enterprise Value
601.77M 2.40B 1.67B 1.75B 1.91B
EV to EBITDA
10.11 -2.60 6.40 7.49 13.44
EV to Sales
1.89 5.42 4.07 4.22 4.90
EV to Free Cash Flow
7.67 13.11 6.11 6.68 11.42
EV to Operating Cash Flow
7.66 13.09 6.11 6.67 11.30
Tangible Book Value Per Share
-2.09 -2.25 4.23 3.73 0.39
Shareholders’ Equity Per Share
-2.08 -2.23 4.23 3.73 0.39
Tax and Other Ratios
Effective Tax Rate
2.36 -0.09 0.31 -1.63 0.02
Revenue Per Share
1.97 2.85 2.66 2.55 2.44
Net Income Per Share
-0.20 -6.45 1.13 3.26 0.67
Tax Burden
-1.31 1.06 0.69 2.63 0.98
Interest Burden
0.42 -4.84 0.97 0.87 0.79
Research & Development to Revenue
0.36 0.26 0.11 0.17 0.23
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.08 0.07 0.07 0.05 0.08
Income Quality
-2.43 -0.18 1.56 0.50 1.59
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis